ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1921

Axial Psoriatic Arthritis: Correlation Between Whole Spine MRI Abnormalities and Clinical Findings

Pamela Diaz1, Iris Eshed2, Joy Feld3 and Lihi Eder1, 1University of Toronto, Toronto, ON, Canada, 2Sheba Medical Center, Ramat Gan, Israel, 3Carmel and Zvulun Medical Centre, Haifa, Israel

Meeting: ACR Convergence 2021

Keywords: Diagnostic criteria, Magnetic resonance imaging (MRI), Psoriatic arthritis, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes II (1919–1922)

Session Type: Abstract Session

Session Time: 2:30PM-2:45PM

Background/Purpose: Psoriatic Arthritis (PsA) typically affects peripheral joints, but in some patients the disease can involve the spine. While magnetic resonance imaging (MRI) is an important diagnostic tool for spondyloarthritis, especially in early phases, there is minimal information about MRI features of axial PsA.
The purpose of the study was to describe the prevalence of inflammatory and structural lesions by whole-spine MRI in patients with psoriatic disease, and assess the correlation of MRI-defined spondyloarthritis (MRI-SpA) with clinical and laboratory features and with classification criteria for axial spondyloarthritis (axSpA).

Methods: In this retrospective analysis we included 93 patients selected from 2 populations: 1) 41 patients with active PsA, who were referred for a whole-spine MRI irrespective of whether they had axial symptoms, and 2) 52 patients with psoriasis and suspected or confirmed PsA who were referred to a whole-spine MRI for suspected axPsA. Patients on biologic advanced therapies were excluded.
Clinical, radiographic and laboratory data were analyzed. Inflammatory back pain (IBP) was defined according to 3 criteria: Berlin, Assessment of Spondyloarthritis International Society (ASAS) and rheumatologist impression.
MRI scans of the sacroiliac joints and whole-spine (T1W and STIR) were assessed by a musculoskeletal radiologist blinded to the clinical and radiographic data. MRI-SpA was defined as: 1) ASAS consensus for active spondylitis/sacroiliitis, and 2) the radiologist impression (considering inflammatory and structural lesions).
The agreement between MRI-SpA as a gold standard, and the ASAS classification criteria for axSpA and different definitions of IBP was assessed. Logistic regression evaluated the association between MRI-SpA and clinical, demographic and laboratory factors.

Results: 93 patients were analyzed (mean age 43.3 ±13, 52.7% women, Table 1). The prevalence of HLA-B*27 was 10.9%. Axial symptoms were present in 81.7%, being defined as IBP in 36.6%/36.6%/57% according to Berlin, ASAS and rheumatologist criteria, respectively. MRI-SpA was found in only 9 (9.7%) patients by ASAS definition and 12 (12.9%) by radiologist impression.
Overall, low agreement was found between the three IBP definitions and MRI-SpA (Table 2). IBP by rheumatologist impression was the most sensitive (50-56%) and ASAS and Berlin criteria for IBP were most specific (62-63%). Poor sensitivity was found for the ASAS criteria for axSpA and MRI-Spondylitis (ASAS definition 22.2%; radiologist impression 25%, Fig. 1). Onset of axial pain after the age of 40 and absence of axial pain accounted for most patients with MRI-SpA not meeting the ASAS axSpA criteria or IBP criteria. Male sex was associated with MRI-Spondylitis (OR 6.9; 95% CI 1.4, 33.6) in multivariable regression analysis.

Conclusion: The overall prevalence of axial inflammatory and structural spondylitis by whole-spine MRI was low despite the high prevalence of axial symptoms. Poor correlation was found between imaging and clinical findings highlighting the need for further research of the underlying mechanisms of axial involvement in PsA.

* Patients with active PsA who were referred for a whole-spine MRI regardless of axial symptoms. † Patients with psoriasis and confirmed or suspected PsA, referred for a whole-spine MRI due to suspected axial PsA. ‡ At least 1 syndesmophyte. § Spondylitis and/or sacroiliitis according to ASAS. (Spondylitis: anterior/posterior BME in ≥3 sites / fatty lesions at several sites. Active sacroiliitis: ≥2 BME lesions on a single SIJ slice and/or ≥ 1 BME lesion on 2 consecutive slices.) ¶ Spondylitis and/or sacroiliitis according to radiologist impression (considering inflammatory and structural lesions).

* Inflammatory back pain according to rheumatologist impression at the clinical visit (considering symptoms but no images) 1. Rudwaleit M, et al. Arthritis Rheum. 2006;54(2):569-78. 2. Sieper J, et al. Ann Rheum Dis. 2009;68(6):784-8.

*Spondylitis and/or sacroiliitis according to ASAS/OMERACT definitions (Spondylitis: anterior/posterior BME in ≥ 3 sites / fatty lesions at several sites. Sacroiliitis: ≥ 2 BME lesions on a single SIJ slice and/or ≥ 1 BME lesion on 2 consecutive slice). † Spondylitis and/or sacroiliitis according to radiologist impression (considering inflammatory and structural lesions)


Disclosures: P. Diaz, None; I. Eshed, Novartis, 6, Abbvie, 6; J. Feld, None; L. Eder, Pfizer, 1, 5, UCB, 5, Abbvie, 1, 5, Novartis, 2, Eli Lily, 1, 5, Fluidigm, 5, 12, Family member - employee, Janssen, 5.

To cite this abstract in AMA style:

Diaz P, Eshed I, Feld J, Eder L. Axial Psoriatic Arthritis: Correlation Between Whole Spine MRI Abnormalities and Clinical Findings [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/axial-psoriatic-arthritis-correlation-between-whole-spine-mri-abnormalities-and-clinical-findings/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/axial-psoriatic-arthritis-correlation-between-whole-spine-mri-abnormalities-and-clinical-findings/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology